South and Central America Kidney Disease Market Growth Drivers and Forecast by 2027

The South & Central America kidney disease market is expected to reach US$ 9,060.9 million in 2027 from US$ 5,758.9 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020-2027.

Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.

Brazil Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)

Market Insights
Increased Contribution by the Governments of the Countries

Every government of the countries in the South & Central America region is now focusing on boosting the healthcare sector and fund various programs to raise awareness about kidney diseases. As per the report published in December 2018 called‘ Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region,’ concerning capacity building and education, an average of 10 to 11 nephrologists have been trained yearly under the ISN(International Society of Nephrology) Fellowship Program support. Besides, from 2009 to 2017, the region graduated 4 Sister Renal Center programs (a program designed to nurture a partnership between centers by supplying a framework and list of benefits) while 6 remain active.  Centers have received eight grants from the ISN Clinical Research Program since 2010 to support projects that may help understand the local reality and test strategies addressing regional challenges. It implies intraregional support from those with higher development and capacity to those in greater need of generating highly qualified human resources. The ISN has identified a series of regional centers of excellence, identified as sites that can and should offer support in training for clinical or research purposes. Thus, an increase in the contribution of the government of the countries is likely to create lucrative opportunities for market growth.

Product- Based Market Insights

Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End-User - Based Market Insights

Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

South & Central America Kidney Disease Market, by End-User – 2019 and 2027

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

South and Central America Kidney Disease Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Product launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the kidney disease market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance,In September 2020, F. Hoffmann-La Roche Ltd. acquired a biotech firm,Inflazome. This acquisition will grant Roche full rights to Inflazome's portfolio of clinical and pre-clinical NLRP3 inhibitors. The business plans to develop NLRP3 inhibitors in a variety of indications.

SOUTH & CENTRAL AMERICAKIDNEY DISEASE MARKET SEGMENTATION

By Product

• Diagnosis

o      Blood Tests

o      Urine Tests

o      Imaging Tests

o      Others

• Treatment

o      Dialysis

o      Others

o      Drug Class

• • • ACE Inhibitors
    • Angiotensin-II Receptor Blockers
    • Diuretics
    • Others

By End User

• Hospitals
• Diagnostic Laboratories
• Others

By Country

• South & Central America

o      Brazil

o      Argentina

Company Profiles

• Abbott
• F. Hoffmann-La Roche Ltd
• AbbVie Inc
• Pfizer Inc
• Teva Pharmaceutical Industries Ltd
• GlaxoSmithKline plc
• Sysmex Corporation
• Siemens AG
• Amgen Inc

South and Central America Kidney Disease Market Report Scope

South and Central America Kidney Disease Market Players Density: Understanding Its Impact on Business Dynamics

The South and Central America Kidney Disease Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.